Thiazolidinediones in the treatment of patients with Post-Transplant-Hyperglycemia or new-onset diabetes mellitus after renal transplantation (NODAT) - A new therapeutic option?

Wien Klin Wochenschr. 2010 Apr;122(7-8):198-202. doi: 10.1007/s00508-010-1369-2.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Cohort Studies
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / mortality
  • Humans
  • Hyperglycemia / drug therapy*
  • Hyperglycemia / mortality
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Kidney Transplantation*
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / mortality
  • Prognosis
  • Survival Rate
  • Thiazolidinediones / adverse effects
  • Thiazolidinediones / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • 2,4-thiazolidinedione